Project Grant R01MH142618
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a $534,191 Project Grant to The Trustees of Columbia University in the City of New York (Health Sciences Division) effective April 1, 2026, through December 31, 2030, under the Mental Health Research Grants program (CFDA 93.242). The award funds research on genetic discovery for neuropsychiatric traits using deep phenotype data. The project addresses a critical gap in psychiatric genetics by developing novel...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Colorado a $730,338 Project Grant effective May 1, 2026, through January 31, 2031, under the Mental Health Research Grants program (CFDA 93.242). The project, titled "Identifying Genetically Distinguishable Subgroups Within Major Depressive Disorder," will deliver two primary research products: (1) the largest genome-wide association studies (GWAS) to date examining multiple major...
- Cooperative Agreement Summary The National Institute of Mental Health (NIMH) awarded The Broad Institute, Inc. a $2.43M Cooperative Agreement (CFDA 93.242: Mental Health Research Grants) effective July 1, 2026, through June 30, 2031, to establish and operate the Mental Health Genomics Consortium Coordinating Center (GC3). The GC3 will serve as a centralized infrastructure hub to advance psychiatric genetics research by consolidating NIMH-supported genomics datasets and enabling collaborative...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a Project Grant totaling $183,118 on September 1, 2025, under the Mental Health Research Grants program (CFDA 93.242). Under the direction of Dr. Tubbs, this research initiative will deliver integrated genomic and electronic health record (EHR) analyses designed to advance precision psychiatry by addressing critical gaps in translating genetic findings to clinical practice. The...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital Research Management Division a $412,500 Project Grant (CFDA 93.242 – Mental Health Research Grants) effective September 1, 2025 through August 31, 2027 to develop a copy number variant (CNV) discovery pipeline for integrated genome-exome sequencing. The project addresses a critical research gap in neuropsychiatric disorder genomics by creating computational and analytical...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $124,128 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded December 15, 2025, with a completion date of December 14, 2031. This award funds a longitudinal neuroimaging research study investigating how structure-function (S-F) coupling in human brain networks changes from birth through adolescence and its relationship to...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Pittsburgh $437,250 under the Mental Health Research Grants program (CFDA 93.242) for a two-year exploratory research project running from April 1, 2026, through March 31, 2028. This R21 award supports basic neuroscience research investigating parvalbumin interneuron (PVI) diversity and plasticity in the primary visual cortex and prefrontal cortex, with the goal of clarifying the relationship...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $572,294 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded August 1, 2026, with completion targeted for July 31, 2029. This three-year research initiative investigates the neurobiological mechanisms by which adolescent social isolation contributes to psychiatric disorder risk in adulthood, with specific focus on glial cell...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Johns Hopkins University a Project Grant of $197,640 under the Mental Health Research Grants program (CFDA 93.242), effective September 1, 2025 through August 31, 2030. This award supports an early-career investigator's research into the functional consequences of schizophrenia-associated genetic variants in GRIA3, a gene encoding the GluA3 subunit of the AMPA receptor...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $117,747 to The Regents of the University of California, San Francisco under the Mental Health Research Grants program (CFDA 93.242) effective June 1, 2026, through May 31, 2028. This K99/R00 Pathway to Independence Award funds research to functionally characterize schizophrenia-related risk genes and genetic variants and their effects on neurogenesis using cerebral organoids as an experimental model system. The...
Award Summary: Psychiatric Genomics Consortium - Mechanisms and Translation The National Institute of Mental Health (NIMH) awarded a $1,299,427 Project Grant (CFDA 93.242: Mental Health Research Grants) to the University of North Carolina at Chapel Hill, effective August 1, 2026 through July 31, 2031. This award funds the Psychiatric Genomics Consortium (PGC), an established research collaborative that has advanced psychiatric genetics research for nearly two decades with over 1,700 investigators and 755 publications. The consortium will deliver integrated genetic discovery and mechanistic research products through three coordinated research aims: (1) identification and rigorous analysis of genetic variants associated with serious psychiatric disorders affecting Americans using state-of-the-art methods to analyze common, rare, and structural variants; (2) dissection of disorder heterogeneity by examining shared and distinct genetic influences on risk across psychiatric and chronic medical conditions; and (3) advancement of mechanistic understanding of psychiatric risk and resilience through fine-mapping of genetic loci, identification of relevant biological contexts, and integration of functional genomic annotations. The award leverages the PGC's established analytical infrastructure and organizational structure to deliver biological and clinical insights into the genetic architecture of psychiatric disorders, with the ultimate objective of improving patient outcomes. The research incorporates data from both domestic and international sites, recognized as scientifically essential to achieve the sample sizes necessary for robust genetic discovery. Deliverables will include foundational genomic datasets, mechanistic findings, peer-reviewed publications, and training and outreach materials advancing understanding of how genetic factors contribute to mental and physical health outcomes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $191.0k | 7/17/26 | ||
| Not listed | $1.1m | 7/7/26 |